ZOGENIX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-07-13: Reporting owner BREITMEYER JAMES B; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-07-13: Reporting owner MAST ERLE T; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-07-13: Reporting owner WIGGINS MARK C; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-07-13: Reporting owner BOCK LOUIS C; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-07-13 | BREITMEYER JAMES B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-07-13 | MAST ERLE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-07-13 | WIGGINS MARK C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-07-13 | BOCK LOUIS C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-07-13 | TANNENBAUM RENEE P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-07-13 | GARNER CAM L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-07-13 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.99 exercise price | 2016-07-15 | |
| 2016-03-14 | FARR STEPHEN J Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $10.35 exercise price | 2016-03-16 | |
| 2016-03-14 | Galer Bradley S. Officer (EVP/Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $10.35 exercise price | 2016-03-16 | |
| 2016-03-14 | Farfel Gail M Officer (EVP/Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $10.35 exercise price | 2016-03-16 | |
| 2016-03-14 | RHOADS ANN D Officer (EVP, CFO, Treasurer & Sec.) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $10.35 exercise price | 2016-03-16 | |
| 2016-03-14 | Darcis Thierry J.P. Officer (EVP / General Manager, Europe) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $10.35 exercise price | 2016-03-16 |